From: Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach
Total complete results
1,020 (84.3%)
Negative
932 (91.4%)
Positive
80 (7.8%)
Discordant results
8 (0.8%)
Incomplete results
190 (15.7%)
Total number of cases
1210 (100%)